✦ LIBER ✦

Lithium-induced changes in plasma amino acid levels during treatment of affective disorders

✍ Scribed by William P. Leighton; Seymour Rosenblatt; J.D. Chanley

Book ID: 119094454
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 590 KB
Volume: 8
Category: Article
ISSN: 0165-1781
DOI: 10.1016/0165-1781(83)90136-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevation of erythrocyte glycine levels

Elevation of erythrocyte glycine levels during lithium treatment of affective disorders

✍ Seymour Rosenblatt; William P. Leighton; J.D. Chanley 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 801 KB

Evolution of plasma homovanillic acid (H

Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorder

✍ Andre Galinowski; Christian Castelnau; Odile Spreux-Varoquaux; Marie-Chantal Bou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Lithium Treatment in Affective Disorders

Lithium Treatment in Affective Disorders from Viewpoint of Transcultural Psychopharmacology: Therapeutic Plasma Level

✍ Ryo Takahashi; Yoshibumi Nakane; Akinori Akiyama 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

Drug plasma levels and platelet 5-HT upt

Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.

✍ K Wood; C Swade; M Abou-Saleh; P Milln; A Coppen 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

The utility of measuring plasma levels o

The utility of measuring plasma levels of antidepressants in the treatment of affective disorders

✍ M. Ackenheil; H.-J. Kuss 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 120 KB

Significance of the changes in plasma am

Significance of the changes in plasma amino-acid levels in meningococcal infection

✍ R. Conejero; A. Lorenzo; F. Arnal; J. Garcia 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 451 KB

A series of patients with meningococcal infections have been studied and divided in two groups: Group I patients with meningococcal sepsis and group II, those with meningococcal meningitis. Patients in group I presented with more severe encephalopathy, shock, DIC and acute systemic complications. Bo